We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · January 20, 2021

Model Using Noninvasive Markers Predicts Very Low HCC Risk After Viral Response in HCV-Advanced Fibrosis

Hepatology (Baltimore, Md.)


Additional Info

Hepatology (Baltimore, Md.)
A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus–Advanced Fibrosis
Hepatology 2020 Dec 01;72(6)1924-1934, S Alonso López, ML Manzano, F Gea, ML Gutiérrez, AM Ahumada, MJ Devesa, A Olveira, BA Polo, L Márquez, I Fernández, JCR Cobo, L Rayón, D Riado, S Izquierdo, C Usón, Y Real, D Rincón, CM Fernández-Rodríguez, R Bañares

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading